Farmacocinetica del triazolam oral en niños
Descargas
Publicado
Cómo citar
Número
Sección
Palabras clave:
triazolamResumen
Es sorprendente encontrar un trabajo sobre triazolam, y más, en niños. En efecto, después de la controversia generada en torno al triazolam y sus posibles efectos secundarios, que obligó al laboratorio a reducir las dosificaciones de sus presentaciones frente a su posible retirada, encontramos este trabajo con el propósito de determinar la farmacocinética del triazolam en niños.
Descargas
Citas
Karl HW, Milgrom P, Domoto P, Kharasch ED, Coldwell SE, Weinstein P, Leroux B, Awamura K, Mautz D. Pharmacokinetics of Oral Triazolam in Children. J Clin Psychopharmacol 1997;17:169-72. https://doi.org/10.1097/00004714-199706000-00005
Meyer ML, Mourino AP, Farrington FH. Comparision of triazolam to a chloral hydrate/hydroxyzine combination in the sedation of pediatric dental patients. Pediatr Dent 1990; 12:283-7.
Quarnstrom FC, Milgrom P, Moore PA. Experience with triazolam in preschool children. Anesth Pain Control Dent 1992;1:157-9.
Depner K, Coldwell S, Awamura K, Preston K, Milgrom P. Visual effects of triazolam in children (abstract 2081). Paper presented at the International Association for Dental Research. San Francisco; 1996.
Awamura K, Coldwell S, Depner K, Milgrom P, Domoto P. Memmory effects of triazolam in children (abstract 1998). Paper presented at the International Association for Dental Research. San Francisco; 1996.
Sprafkin J, Gadow KD. Double-blind versus open evaluations of drug response in children with attention-deficit hyper¬activity disorder. J Child Adolesc Psychopharmacol 1996; 4:215-28. https://doi.org/10.1089/cap.1996.6.215
Pleak RR, Gormly J. Effects of venlafaxine treatment for ADHD in a child (letter). Am J Psychiatry 1995;152:1099. https://doi.org/10.1176/ajp.152.7.1099a
Derivan A, Aguiar L, Upton GV, Martin P, D'Amico D, Troy S, Ferguson J, Preskom SA. Study of venlafaxina in children and adolescent with conduct disorder (abstract). New Orleans (LA): Annual Meeting of the American Academy of Child and Adolescent Psychiatry. 1995. p. 128.
Mandoki M. Effects of venlafaxina in major depression in children and adolescent (letter). New Orleans (LA): Annual Meeting of the American Academy of Child and Adolescent Psychiatry. 1995. p. 127.
Olvera RL, Pliska SR, Luh J, Tatum R. An open Trial of Venlafaxina in the treatment of Attention-Deficit/ Hiperactivity Disorder in children and adolescent. J Child Adolesc Psyohopharmacol 1996;4:241-50. https://doi.org/10.1089/cap.1996.6.241